Purchase Order HHSN272201600452P

The U.S. government awarded a $3,194.98 firm fixed-price purchase order to Genscript USA Inc. on May 5, 2015, for custom gene synthesis services. The contract, with an ultimate completion date of September 30, 2015, was funded by a civilian agency within the Midwest Area and performed at the contractor's facility in Piscataway, New Jersey. No set-aside designation was applied to this award. Genscript USA Inc., a biotechnology company specializing in advanced molecular biology services, has...

The U.S. government awarded a $2,656 firm fixed-price purchase order to Genscript USA Inc. for molecular biology services on July 28, 2018, with an ultimate completion date of August 15, 2018. The contract, issued by the Pacific West Area civilian agency, calls for the synthesis of a CAMV 35S promoter followed by a CTV-RB115 sequence consisting of 5,711 base pairs and the cloning of this sequence in pBluescript II SK(+) vector. The work will be performed at Genscript's facility in Piscataway,...

The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $248,857.00 Firm Fixed Price purchase order to Genscript USA Inc., a biotechnology company, for the provision of "FAST GENE SYNTHESIS" services. The contract has an August 7, 2023 completion date and was awarded on August 8, 2022. Genscript is a for-profit organization that provides gene synthesis, gene editing, custom protein and antibody production, and other molecular biology services to...

This firm fixed-price purchase order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $3,943.72 contract is for custom gene synthesis services to support NIAID's biomedical research programs. Genscript, a for-profit organization, has a strong track record of providing specialized molecular biology products and services to...

Genscript USA Incorporated will provide gene synthesis and vector ark cloning services to the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). Under the terms of a $12,108 firm fixed price purchase order, Genscript will deliver the requested products and services between September 2023 and September 2024. As the prime contractor, Genscript will leverage its expertise...

The U.S. government awarded a $3,681.17 firm fixed-price purchase order to Genscript USA Inc. for protein synthesis services on April 8, 2019, with a completion date of May 31, 2019. The contract was issued by a civilian federal agency within the Pacific West Area and will be performed at Genscript's headquarters in Piscataway, New Jersey. No set-aside designation was applied to this award, making it available to all qualified vendors in full and open competition. Genscript USA Inc., a...

This contract was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Cancer Institute to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey. The $3,182.40 firm fixed price delivery order is for gene synthesis services. Genscript specializes in providing customized DNA, antibodies, proteins, peptides, and other molecular biology products and services to support biomedical research and public health initiatives...

The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $702,500 firm-fixed-price contract to Genscript USA Inc. to provide gene synthesis services in support of COVID-19 testing. Under the contract, Genscript will synthesize 150 genes and conduct 150 mutagenesis and 250 express cloning projects, as well as prepare 425 plasmids. These products and services will support the testing of COVID-19 antibody therapeutics, convalescent plasma, and vaccines...

This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Genscript USA Inc., a for-profit biotechnology company, for custom gene synthesis services. The contract has a potential value of $21,275.80 and a completion date of August 19, 2020. Genscript, based in Piscataway, New Jersey, specializes in gene synthesis, gene editing, custom protein and...

This firm fixed-price purchase order, valued at $14,607.70, was awarded by the National Institute of Child Health and Human Development (NICHD) to Genscript USA Inc. for gene synthesis and cloning services. The ultimate completion date is August 29, 2024. Genscript is a biotechnology company based in Piscataway, New Jersey that specializes in molecular biology products and services to support biomedical research and public health initiatives for various federal agencies, including the National...